A Study of JNJ-61393215 in the Treatment of Depression

NCT04080752 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

222

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder With Anxious Distress

Interventions

DRUG: JNJ-61393215
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC